Recent Advances in Ovarian Cancer Surgery
A special issue of Cancers (ISSN 2072-6694). This special issue belongs to the section "Cancer Therapy".
Deadline for manuscript submissions: 30 September 2024 | Viewed by 319
Special Issue Editor
2. INSERM UMR-S 1147, University of Paris Cité, Centre de Recherche des Cordeliers, 75006 Paris, France
3. Institut du Cancer Paris CARPEM, 75006 Paris, France
Interests: gynecological cancers; epithelial ovarian cancer; gynecological surgery; photodynamic therapy; tumor-circulating DNA
Special Issue Information
Dear Colleagues,
Surgery for ovarian cancer, especially at an advanced stage, has evolved over the last few years with the reduction in indications for lymph node dissection, the rise of hyperthermic intraperitoneal chemotherapy (HIPEC) in interval cytoreductive surgery (CRS), and the strengthening of the place for secondary CRS in case of recurrence.
The quality of surgery remains the main prognostic factor for the survival of patients. Progress must still be made to improve the precision of the interventions, the selection of the patients, and their preparation. Thus, we propose this Special Issue to highlight the expected innovations in ovarian cancer surgery in the era of personalized therapies, timing in an optimized therapeutic sequence, the potential benefits of minimally invasive surgery (laparoscopy or robot-assisted) and HIPEC, the role of fluorescence, or the impact of enhanced rehabilitation in surgery, with the objective that future progress will improve the prognosis of patients, but also their quality of life.
Dr. Henri Azaïs
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- epithelial ovarian cancer
- hyperthermic intraperitoneal chemotherapy
- minimally invasive surgery
- robotic surgery
- fluorescence guided surgery
- lymph node dissection
- enhanced recovery
- photodynamic therapy
